{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T17:07:20Z","timestamp":1773248840843,"version":"3.50.1"},"reference-count":26,"publisher":"S. Karger AG","issue":"1-2","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecol Obstet Invest"],"published-print":{"date-parts":[[2021]]},"abstract":"<jats:p>&lt;b&gt;&lt;i&gt;Objective:&lt;\/i&gt;&lt;\/b&gt; The aim of the study was to determine the influence of beta-adrenoceptor (ADRB) antagonists on contractile activity of the nonpregnant human uterus in patients affected by gynecological malignancies. &lt;b&gt;&lt;i&gt;Design:&lt;\/i&gt;&lt;\/b&gt; This was a controlled and prospective ex vivo study. &lt;b&gt;&lt;i&gt;Setting:&lt;\/i&gt;&lt;\/b&gt; The work was conducted as a collaboration between 4 academic departments. &lt;b&gt;&lt;i&gt;Materials and Methods:&lt;\/i&gt;&lt;\/b&gt; Myometrial specimens were obtained from women undergoing hysterectomy for benign gynecological disorders (reference group; &lt;i&gt;N&lt;\/i&gt; = 15), and ovarian (&lt;i&gt;N&lt;\/i&gt; = 15), endometrial (&lt;i&gt;N&lt;\/i&gt; = 15), synchronous ovarian-endometrial (&lt;i&gt;N&lt;\/i&gt; = 3), and cervical cancer (&lt;i&gt;N&lt;\/i&gt; = 10). Contractions of myometrial strips in an organ bath before and after applications of ADRB antagonists (propranolol, bupranolol, SR 59230A, and butoxamine) were studied under isometric conditions. &lt;b&gt;&lt;i&gt;Results:&lt;\/i&gt;&lt;\/b&gt; Propranolol and bupranolol attenuated contractions in the endometrial and cervical cancer groups similar to that in the reference group (all &lt;i&gt;p&lt;\/i&gt; &amp;#x3c; 0.05), whereas opposite effects were observed in the ovarian and synchronous ovarian-endometrial cancer groups. SR 59230A and butoxamine significantly increased contractions in the ovarian cancer group (both &lt;i&gt;p&lt;\/i&gt; &amp;#x3c; 0.001). &lt;b&gt;&lt;i&gt;Limitations:&lt;\/i&gt;&lt;\/b&gt; These results require now to be placed into a firm clinical context. &lt;b&gt;&lt;i&gt;Conclusions:&lt;\/i&gt;&lt;\/b&gt; Our study indicates that ovarian cancer considerably alters contractile activity of the nonpregnant human uterus in response to ADRB antagonists. This suggests a pathogenetic role of beta-adrenergic pathways in this malignancy. Furthermore, propranolol and bupranolol substantially influence spontaneous uterine contractility. <\/jats:p>","DOI":"10.1159\/000513718","type":"journal-article","created":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T21:06:51Z","timestamp":1617052011000},"page":"162-169","source":"Crossref","is-referenced-by-count":3,"title":["Myometrial Responses to Beta-Adrenoceptor Antagonists in Gynecological Malignancies"],"prefix":"10.1159","volume":"86","author":[{"given":"Beata","family":"Modzelewska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcin","family":"J\u00f3\u017awik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Kleszczewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanis\u0142aw","family":"Sulkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej","family":"J\u00f3\u017awik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"127","published-online":{"date-parts":[[2021,2,26]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/ph13060105"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g2301"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2174\/1381612033454487"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2009.00616.x"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s12576-016-0500-1"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2001.tb03801.x"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1023\/B:CACO.0000036152.58271.5e"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1023\/a:1023228925137"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2217\/fon.10.142"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1159\/000298801"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3109\/00016348909028672"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1515\/pjvs-2017-0015"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199811000-00001"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0233"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030692"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1113\/eph8602180"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s0306-3623(98)00287-0"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-16-0858"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2013.08.009"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2010.10.012"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-10-0358"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2413"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29392"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.18632\/oncoscience.357"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-1701"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2013.03.016"}],"container-title":["Gynecologic and Obstetric Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/513718","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/513718","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T16:17:29Z","timestamp":1745425049000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000513718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":26,"journal-issue":{"issue":"1-2","published-online":{"date-parts":[[2021,5,20]]},"published-print":{"date-parts":[[2021,5,25]]}},"URL":"https:\/\/doi.org\/10.1159\/000513718","archive":["Portico"],"relation":{},"ISSN":["0378-7346","1423-002X"],"issn-type":[{"value":"0378-7346","type":"print"},{"value":"1423-002X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]}}}